We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

En Español

Frequently Asked Questions

Get answers to common questions about the Genentech Patient Foundation.

Patient Questions

Additional Questions for Health Care Providers



If any of your questions weren’t answered here, call us at (888) 941-3331.